Neoadjuvant Chemotherapy Combined With Targeted Treatment in High-risk Retroperitoneal Sarcoma
Condition(s):Retroperitoneal SarcomaLast Updated:May 12, 2023Enrolling by invitation
Hide Studies Not Open or Pending
Condition(s):Retroperitoneal SarcomaLast Updated:May 12, 2023Enrolling by invitation
Condition(s):IgG4-related DiseaseLast Updated:February 28, 2023Not yet recruiting
Condition(s):Retroperitoneal FibrosisLast Updated:December 8, 2022Recruiting
Condition(s):Moyamoya DiseaseLast Updated:March 10, 2021Withdrawn
Condition(s):Aneurysmal Subarachnoid HemorrhageLast Updated:December 1, 2023Recruiting
Condition(s):Cerebral Arteriovenous MalformationLast Updated:October 20, 2020Recruiting
Condition(s):Moyamoya Disease; Ischemic Cerebral Infarction; Ischemic Stroke; Ischemic Cerebrovascular Accident; Transient Ischemic AttackLast Updated:December 19, 2019Unknown status
Condition(s):Arteriovenous Malformation of BrainLast Updated:November 30, 2020Recruiting
Condition(s):Cavernous Malformation, Cerebral; Cavernous Angioma; Cavernous Hemangioma; Cavernous Hemangioma of Brain; Seizures; Seizures, Epileptic; EpilepsyLast Updated:September 4, 2019Recruiting
Condition(s):Moyamoya Disease; Remote Ischemic PreconditioningLast Updated:September 19, 2019Suspended
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.